“…Nevertheless, the prevalence of maternal antenatal antidepressant use in our sample corresponded to the general Finnish population (Malm et al., ), supporting the representativeness of our sample. On the other hand, while we focused on the effects of maternal depressive symptoms on child neurodevelopment, depression is highly comorbid with anxiety also in the perinatal period (Falah‐Hassani, Shiri, & Dennis, ), and maternal antenatal anxiety has also been shown to affect child neurodevelopment (Buss, Davis, Hobel, & Sandman, ; O'Donnell et al., ; Van den Bergh et al., ). Hence, further studies disentangling the unique effects of maternal depression and anxiety on child neurodevelopment are warranted.…”